Alzheimer's Disease International (ADI)
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
ADI, in collaboration with academics from the London School of Economics, published a commentary in Nature Reviews Neurology urging governments to include dementia in NCD policies and frameworks. This paper reveals striking data, including dementia becoming the 3rd leading cause of death globally by 2040 and among the top 10 causes of death in 166 countries.
On 10 December, ADI launched its inaugural End of Year Forecast, focusing on ‘Translating the Alzheimer's Treatment Revolution into Real World Solutions’. This event sought to highlight the new era for Alzheimer’s treatments and cut through the often confusing and cryptic information that is available to the general public. ADI is pleased to share the slide featured in this event. Make sure to scroll down the page to see all 127 Alzheimer’s treatments and their place in the pipeline.
ADI is pleased to welcome both Her Majesty The Queen Sofía of Spain and Her Royal Highness Princess Muna Al Hussein of Jordan to ADI’s 36th International Conference
ADI’s Director of the Americas attends the ReD-Lat Annual Meeting in Buenos Aires, Argentina with the aim to strengthen the bonds between ADI's members and researchers attending ReD-Lat; fostering collaboration and knowledge exchange to advance the field of dementia research in Latin America and the Caribbean.
As the global voice on dementia, ADI has embarked on impactful week of advocacy in Europe and beyond. Attending the WHO Executive Board meetings in Geneva, a high level meeting of health ministries at OECD, Paris, and virtually joining the HGPI in Japan. With key members of ADI staff making multiple addresses to international bodies seeking to improve and strengthen policies that relate to dementia.
AD-RIDDLE, funded by the Innovative Health Initiative, a European Union public privative partnership, brings together academics, healthcare providers, pharmaceutical companies, regulatory bodies to develop tools and resources for healthcare providers.
ADI calls for lived experience to be central to innovation in the field of dementia diagnostics, treatment and care. In her short interview with Novartis, Paola Barbarino highlights key areas which innovators must consider when developing their products and service, from inception, to testing and ultimately bringing them to market; and reminds us not to forget that simple innovative changes can lead to great impact.
Diego Aguilar, Regional Director for the Americas gives his insights on the recent ADI members meeting for Latin America and the Caribbean, held in San Juan, Puerto Rico in early December 2023.
DY Suharya, Director of ADI Asia Pacific, and Shyh Poh Teo, Director of Demensia Brunei, reflect on the 2023 Asia Pacific Regional Conference as co-organisers of the event.
This November, African regional members from across the continent including Botswana, Burundi, Cameroon, Ethiopia, France, Ghana, Kenya, Madagascar, Mauritius, Nigeria, Sénégal, South Africa, Uganda and Zimbabwe, convened in…